BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9607645)

  • 1. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics.
    Ramos-Casals M; Cervera R; Font J; García-Carrasco M; Espinosa G; Reino S; Pallarés L; Ingelmo M
    Lupus; 1998; 7(3):202-6. PubMed ID: 9607645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics.
    García-Carrasco M; Cervera R; Rosas J; Ramos-Casals M; Morlà RM; Sisó A; Jiménez S; Pallarés L; Font J; Ingelmo M
    Lupus; 1999; 8(1):20-3. PubMed ID: 10025595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
    Tishler M; Yaron I; Shirazi I; Yaron M
    J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Sjögren's syndrome in men: clinical and immunological characteristics.
    Cervera R; Font J; Ramos-Casals M; García-Carrasco M; Rosas J; Morlà RM; Muñoz FJ; Artigues A; Pallarés L; Ingelmo M
    Lupus; 2000; 9(1):61-4. PubMed ID: 10713648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
    Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
    Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance.
    Soto-Cardenas MJ; Perez-De-Lis M; Bove A; Navarro C; Brito-Zeron P; Diaz-Lagares C; Gandia M; Akasbi M; Siso A; Ballester E; Torres A; Ramos-Casals M
    Clin Exp Rheumatol; 2010; 28(5):647-53. PubMed ID: 20883638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
    Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
    J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
    Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
    Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?
    Anquetil C; Hachulla E; Machuron F; Mariette X; Le Guern V; Vittecoq O; Dernis E; Larroche C; Dubost JJ; Perdriger A; Devauchelle-Pensec V; Fauchais AL; Morel J; Dieudé P; Rist S; Sene D; Gottenberg JE; Hatron PY
    Rheumatology (Oxford); 2019 Jul; 58(7):1163-1167. PubMed ID: 30561748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome.
    Ramos-Casals M; Sánchez-Tapias JM; Parés A; Forns X; Brito-Zerón P; Nardi N; Vazquez P; Vélez D; Arias I; Bové A; Plaza J; Rodés J; Font J
    J Rheumatol; 2006 Aug; 33(8):1593-9. PubMed ID: 16881116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome.
    Tzioufas AG; Boumba DS; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 1996 May; 39(5):767-72. PubMed ID: 8639173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.
    Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
    Autoimmunity; 2015; 48(7):438-44. PubMed ID: 25980318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
    Garcíc-Carrasco M; Font J; Filella X; Cervera R; Ramos-Casals M; Sisó A; Aymamí A; Ballesta AM; Ingelmo M
    Clin Exp Rheumatol; 2001; 19(4):411-5. PubMed ID: 11491496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome.
    Tomi AL; Belkhir R; Nocturne G; Desmoulins F; Berge E; Pavy S; Miceli-Richard C; Mariette X; Seror R
    Arthritis Rheumatol; 2016 May; 68(5):1245-50. PubMed ID: 26636425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.